Directory
>
Sanjay Subramanian
Sanjay Subramanian
Chief Financial Officer | Inozyme Pharma
New Jersey, United States
Sanjay Subramanian
Summary
Sanjay Subramanian is an accomplished Chief Financial Officer with extensive experience in corporate finance, mergers and acquisitions, and business strategy. He currently leads financial operations at Inozyme Pharma, where his expertise in capital markets and liquidity management plays a crucial role in driving the company's growth. Sanjay's career spans several high-profile organizations, including Ocugen and Bausch Health Companies, where he has held various leadership positions. With a strong educational background from prestigious institutions such as MIT and IIT Madras, he combines technical knowledge with strategic insight. His ability to navigate complex financial landscapes and lead cross-functional teams sets him apart in the industry. Outside of finance, Sanjay is passionate about innovation and sustainability in business practices, making him a versatile leader in today's dynamic market.
Sanjay Subramanian
Work Experience
Chief Financial Officer at
Inozyme Pharma
March 2022 - Present
Chief Financial Officer and Head of Corporate Development at
Ocugen
October 2019 - March 2022
Chief Financial Officer at
Aralez Pharmaceuticals Canada Inc.
January 2019 - September 2019
VP Finance at
Aralez Pharmaceuticals Canada Inc.
October 2015 - January 2019
Director of Treasury at
Bausch Health Companies Inc.
February 2013 - October 2015
Managing Director, Treasurer - GM Korea Operations at
General Motors
January 2012 - January 2012
Finance Leadership Rotation Program at New York Treasurer's Office (NYTO) at
General Motors
January 2008 - January 2012
Supply Chain Management at
Other
January 1999 - January 2006
Sanjay Subramanian
Education
MIT Sloan School of Management, Master Of Business Administration (Mba)
Massachusetts Institute of Technology, Master Of Science
The Ohio State University, Master Of Science
Frequently Asked Questions about Sanjay Subramanian
What is Sanjay Subramanian email address?
Sanjay Subramanian's primary email address is ************@inozyme.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Sanjay Subramanian work for?
Sanjay Subramanian is a Chief Financial Officer at Inozyme Pharma, a company specializing in Commercial physical research.
Where Sanjay Subramanian graduated from?
Sanjay Subramanian holds a degree in from MIT Sloan School of Management.
How can I directly contact Sanjay Subramanian?
To contact Sanjay Subramanian directly, you can use the email address ************@inozyme.com. Complete contact information is available upon registration with Muraena.
Is Sanjay Subramanian an immigrant?
Yes, Sanjay Subramanian is an immigrant and currently based in United States
Who is Sanjay Subramanian?
Sanjay Subramanian is an accomplished Chief Financial Officer with extensive experience in corporate finance, mergers and acquisitions, and business strategy. He currently leads financial operations at Inozyme Pharma, where his expertise in capital markets and liquidity management plays a crucial role in driving the company's growth. Sanjay's career spans several high-profile organizations, including Ocugen and Bausch Health Companies, where he has held various leadership positions. With a strong educational background from prestigious institutions such as MIT and IIT Madras, he combines technical knowledge with strategic insight. His ability to navigate complex financial landscapes and lead cross-functional teams sets him apart in the industry. Outside of finance, Sanjay is passionate about innovation and sustainability in business practices, making him a versatile leader in today's dynamic market.
Sanjay`s contact details
************@inozyme.com
************@aralez.com
Colleagues
Vice President Information Technology
SVP | Chief Technical Operations Officer
Vice President Worldwide Clinical Operations & Site Strategy
SVP & Chief People Officer
SVP and Chief Medical Officer
Vice President, Head of Program Management
Chief Executive Officer And Chairman
Vice President, Toxicology
Scientific Founder
Vice President, Regulatory Affairs, Medical Writing, and Pharmacovigilance